[Therapy of arrhythmias].
D000404:Ajmaline / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001919:Bradycardia / Q000188:drug therapy; D002110:Caffeine / Q000627:therapeutic use; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006327:Heart Block / Q000188:drug therapy; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014700:Verapamil / Q000627:therapeutic use
D004071:Digitalis Glycosides; D000404:Ajmaline; D002110:Caffeine; D009921:Metaproterenol; D010672:Phenytoin; D008012:Lidocaine; D014700:Verapamil; D011342:Procainamide
Zur Therapie von Herzrhythmusstörungen